EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Exploring Somatic Genomic Alterations in Breast Cancer: Insights from the 100,000 Genomes Project at a Tertiary Care Breast Cancer Centre

Marta D’Auria, Felicity H. Allen, Noor Otey, Hazem Khout

Breast Global Journal · 2024

DOI: 10.4103/bgj.bgj_18_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Global Journal, 2024. Verfasst von Marta D’Auria und 3 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A bstract Introduction: The 100,000 Genomes Project (100KGP), a pioneering British initiative examining the role of genes in health and disease, including breast cancer, reached completion in December 2018, with ongoing data analysis. This study focusses on analysing data from the 100KGP conducted at our tertiary care breast cancer centre, specifically investigating the correlation of somatic mutations and patient outcomes. We specifically looked at which mutations were more prevalent and which were associated with worse clinical outcomes. Materials and Methods: We conducted a comprehensive analysis of data from 100KGP reports, encompassing identified somatic mutations. Electronic records from hospital systems, including pathology, radiology, clinical letters, and correspondence, were scrutinised to determine the incidence of local recurrence, metastasis, and mortality. We reported the incidence, prevalence and mortality rates together with comparative odds ratios and hazard ratios.

Results

A total of 116 patients were diagnosed and recruited for 100KGP, with results available for 96 patients. At the 5-year mark, 82 out of 96 patients remained alive (85.4%). Notably, patients with metastatic disease and those with low-risk disease displayed a comparable number of somatic mutations. The prevalent somatic mutation gene was phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA; 46%), closely followed by tumour protein p53 (TP53; 36%). Half of the patients who died of breast cancer exhibited TP53 mutations. Specifically, ER+ cancers were more likely to have PIK3CA mutations compared to ER– cancers (52.5% vs. 18.7%). While no significant age-related disparity in somatic mutations was observed, cancers of grade 2 and 3 displayed a higher mutation count compared to cancer of grade 1.

Conclusions

Our findings align with those of larger genomic datasets in the existing literature. The final analysis of national results from 100KGP will further shed light on the correlation between somatic mutations and patient outcomes.

Zitieren

APA

D’Auria, M., Allen, F. H., Otey, N., & Khout, H. (2024). Exploring Somatic Genomic Alterations in Breast Cancer: Insights from the 100,000 Genomes Project at a Tertiary Care Breast Cancer Centre. Breast Global Journal. https://doi.org/10.4103/bgj.bgj_18_24

Vancouver

D’Auria M, Allen FH, Otey N, Khout H. Exploring Somatic Genomic Alterations in Breast Cancer: Insights from the 100,000 Genomes Project at a Tertiary Care Breast Cancer Centre. Breast Global Journal. 2024. doi:10.4103/bgj.bgj_18_24

BibTeX
@article{DAuria2024,
  author = {D’Auria, Marta and Allen, Felicity H. and Otey, Noor and Khout, Hazem},
  title = {Exploring Somatic Genomic Alterations in Breast Cancer: Insights from the 100,000 Genomes Project at a Tertiary Care Breast Cancer Centre},
  journal = {Breast Global Journal},
  year = {2024},
  doi = {10.4103/bgj.bgj_18_24}
}
Kostenlos starten →